RBC Capital Downgrades Valeant Pharmaceuticals (VRX) to Sector Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
UPDATE: Canaccord Genuity Downgrades Valeant Pharmaceuticals (VRX) to Hold
March 2, 2016 6:55 AM EST(Updated - March 2, 2016 1:08 PM EST)
Canaccord Genuity downgraded Valeant Pharmaceuticals (NYSE: VRX) from Buy to Hold and lowered its price target to $75 (from $125). Valeant recently confirmed that it has several ongoing investigations, including investigations by the US Attorneys Offices for Massachusetts and the Southern District of New York, the SEC, and Congress.
Analyst Neil Maruoka commented... More
Valeant Pharma (VRX) Pares Earlier Decline
March 1, 2016 2:28 PM ESTValeant Pharma (NYSE: VRX) pared earlier declines to trade lower by only 1.3%.
Valeant (VRX) PT Cut to $106 at Jefferies
March 1, 2016 8:16 AM ESTJefferies analyst David Steinberg lowered his price target on Valeant Pharmaceuticals (NYSE: VRX) to $106.00 (from $172.00) while maintaining a Buy rating.
Steinberg commented, "With the return of CEO Mike Pearson, a critical issue has been addressed. However, a host of equally critical questions have... More
Valeant Pharma (VRX) Provides Statement on SEC Investigation
February 29, 2016 4:41 PM ESTValeant Pharma (NYSE: VRX) said:
"In response to media inquiries, Valeant confirmed that it has several ongoing investigations, including investigations by the US Attorneys Offices for Massachusetts and the Southern District of New York, the SEC, and Congress. With respect to the SEC... More
Valeant Pharma (VRX) Affirms Receipt of SEC Subpoena
February 29, 2016 4:40 PM ESTValeant Pharma (NYSE: VRX) issued the following statement on Monday:
"In response to media inquiries, Valeant confirmed that it has several ongoing investigations, including investigations by the US Attorneys Offices for Massachusetts and the Southern District of New York, the SEC, and... More
Valeant Pharma (VRX) Says It's Under Investigation by SEC
February 29, 2016 3:36 PM EST(Updated - February 29, 2016 3:38 PM EST)
Valeant Pharma (NYSE: VRX) said it's under investigation by the SEC, according to Bloomberg, citing spokesperson Laurie Little. The probe is said to be separate from the Salix investigation.
"In response to media inquiries, Valeant confirmed that it... More
